Atlanta (March 5, 2026) – Piedmont Oncology, via Piedmont Atlanta Hospital, is the first site in the United States to enroll patients in the MOMENTUM-1 clinical trial, which is designed to evaluate a novel therapy for adult patients with progressive intracranial meningioma. Meningioma is a tumor of the lining of the brain or spine.
“We are proud to offer this innovative treatment to Piedmont Oncology patients,” said Walter J. “Wally” Curran, Jr., M.D., FACR, FASCO, the Whitaker Endowed Chief of Piedmont Oncology. “Piedmont cares for patients from all 50 states and the ability to offer this trial demonstrates that the quality of our system ranks among the best in the country.”
Adam Nowlan, M.D., M.P.H., of Piedmont Physicians Radiation Oncology Atlanta, is serving as the local principal investigator. Dr. Nowlan is a member of the clinical trials team at the Piedmont Brain Tumor Center.
Throughout his medical experience, Dr. Nowlan has already published several reports on the management of meningioma patients.
The study involves the use of lutetium Lu-177 dotate, a radioactive drug that is approved by the U.S. Food and Drug Administration to treat patients with other types of rare cancers. The trial is a partnership between the RTOG Foundation, a nonprofit dedicated to improving outcomes for cancer patients through the conduct of practice-changing clinical trials, and Novartis, the manufacturer of lutetium Lu-177 dotate (whose commercial name is Lutathera). Dr. Curran was the founding chairman of the RTOG Foundation.
“The treatment offered in the MOMENTUM-1 trial could represent a major advance for patients with meningiomas, and we are excited to investigate this therapy for these patients,” Dr. Nowlan said.
About Piedmont: Piedmont is empowering Georgians by changing health care. We continue to fuel Georgia’s growth through safe, cost-effective, high-quality care close to home through an integrated health care system that provides a hassle-free, unified experience. We are a private, not-for-profit organization with more than 12,000 donors annually that for centuries has sought to make a positive difference in every life we touch in the communities we serve. Across our 2,171 physical locations we care for more than 4.5 million patients and serve communities that comprise 85 percent of Georgia’s population. This includes 27 hospitals, 115 immediate care locations, 1,875 Piedmont Clinic physician practices and more than 3,600 Piedmont Clinic members. Our patients conveniently engage with Piedmont online, as they scheduled more than 560,000 online appointments and over 120,000 virtual visits. With nearly 50,000 care givers we are the largest Georgia-based private employer of Georgians, who all came for the job, but stayed for the people. In 2024 and 2023, Piedmont has earned recognition from Newsweek as one of America’s Greatest Workplaces for Diversity and also as one of America’s Greatest Workplaces for Women. In 2022, Forbes ranked Piedmont on its list of the Best Large Employers in the United States. Piedmont provided more than $607 million in community impact in Fiscal Year 2024.
For more information, or to book your next appointment, visit piedmont.org. If your messaging client supports TLS for secure connections, then this message was sent securely via TLS from Piedmont Healthcare, Inc.
Leave a Reply
You must be logged in to post a comment.